OneMedNet Adds 2.7M Annual Cardiovascular Studies, Expanding Network
OneMedNet (Nasdaq:ONMD) has significantly expanded its Cardiovascular AG真人官方-World Data (RWD) network by adding 85 cardiovascular centers and data sources, contributing approximately 2.7 million annual cardiovascular studies. This expansion positions OneMedNet as one of the largest providers of cardiovascular RWD.
The enhanced network provides de-identified cardiovascular imaging, diagnostic reports, and electrocardiograms (ECG) to life sciences companies, AI developers, and medical device manufacturers. This data is particularly valuable given that cardiovascular diseases (CVDs) cause 19.8 million deaths globally and generate $320 billion in annual costs in the US alone.
OneMedNet (Nasdaq:ONMD) ha ampliato in modo significativo la sua rete di dati real world cardiovascolari (RWD) inserendo 85 centri e fonti dati cardiovascolari, che forniscono circa 2,7 milioni di esami cardiovascolari annuali. Questa espansione colloca OneMedNet tra i principali fornitori di RWD cardiovascolare.
La rete potenziata mette a disposizione, in forma de-identificata, immagini cardiovascolari, referti diagnostici ed elettrocardiogrammi (ECG) per aziende del settore life sciences, sviluppatori di intelligenza artificiale e produttori di dispositivi medici. Questi dati sono particolarmente importanti se si considera che le malattie cardiovascolari (CVD) causano 19,8 milioni di decessi nel mondo e generano 320 miliardi di dollari di costi annuali solo negli Stati Uniti.
OneMedNet (Nasdaq:ONMD) ha ampliado significativamente su red de datos reales cardiovasculares (RWD) al incorporar 85 centros y fuentes de datos cardiovasculares, aportando aproximadamente 2,7 millones de estudios cardiovasculares anuales. Esta ampliaci贸n sit煤a a OneMedNet como uno de los mayores proveedores de RWD cardiovascular.
La red ampliada ofrece datos desidentificados de im谩genes cardiovasculares, informes diagn贸sticos y electrocardiogramas (ECG) a empresas de ciencias de la vida, desarrolladores de IA y fabricantes de dispositivos m茅dicos. Estos datos son especialmente valiosos dado que las enfermedades cardiovasculares (CVD) causan 19,8 millones de muertes a nivel mundial y generan 320.000 millones de d贸lares en costes anuales solo en EE. UU.
OneMedNet (Nasdaq:ONMD)电� 85臧� 鞁槇甏� 靹柬劙 氚� 雿办澊韯� 於滌矘毳� 於旉皜頃橃棳 鞁槇甏� 鞁れ偓鞖� 雿办澊韯�(RWD) 雱ろ姼鞗岉伂毳� 韥矊 頇曥灔頄堨溂氅�, 鞐瓣皠 鞎� 270毵� 瓯挫潣 鞁槇甏� 瓴�靷�毳� 鞝滉车頃橁碃 鞛堨姷雼堧嫟. 鞚� 頇曥灔鞚� OneMedNet毳� 鞁槇甏� RWD鞚� 欤检殧 鞝滉车鞛� 欷� 頃橂倶搿� 鞛愲Μ毵り箑頃橁矊 頃╇媹雼�.
頇曤寑霅� 雱ろ姼鞗岉伂电� 靸濍獏瓿柬暀 旮办梾, AI 臧滊皽鞛� 氚� 鞚橂旮瓣赴 鞝滌“靷棎 鞚惦獏 觳橂Μ霅� 鞁槇甏� 鞓侅儊, 歆勲嫧 氤搓碃靹� 氚� 鞁爠霃�(ECG)毳� 鞝滉车頃╇媹雼�. 鞚措煬頃� 雿办澊韯暗鐢 鞁槇甏� 歆堩櫂(CVD)鞚� 鞝� 靹戈硠鞝侅溂搿� 1,980毵� 氇呾潣 靷鞚� 齑堧灅頃橁碃 氙戈淡鞐愳劀毵� 鞐瓣皠 3,200鞏� 雼煬鞚� 牍勳毄鞚� 氚滌儩鞁滍偍雼さ鐢 鞝愳棎靹� 韸鬼瀳 臧�旃橁皜 雴掛姷雼堧嫟.
OneMedNet (Nasdaq:ONMD) a consid茅rablement 茅largi son r茅seau de donn茅es r茅elles cardiovasculaires (RWD) en ajoutant 85 centres et sources de donn茅es cardiovasculaires, apportant environ 2,7 millions d'examens cardiovasculaires annuels. Cette expansion positionne OneMedNet parmi les principaux fournisseurs de RWD cardiovasculaire.
Le r茅seau renforc茅 fournit, de mani猫re d茅-identifi茅e, des images cardiovasculaires, des comptes rendus diagnostiques et des 茅lectrocardiogrammes (ECG) aux entreprises des sciences de la vie, aux d茅veloppeurs d'IA et aux fabricants de dispositifs m茅dicaux. Ces donn茅es sont d'autant plus pr茅cieuses que les maladies cardiovasculaires (CVD) causent 19,8 millions de d茅c猫s dans le monde et g茅n猫rent 320 milliards de dollars de co没ts annuels rien qu'aux 脡tats-Unis.
OneMedNet (Nasdaq:ONMD) hat sein Netzwerk f眉r AG真人官方-World-Daten (RWD) im Bereich Herz-Kreislauf deutlich erweitert und 85 kardiovaskul盲re Zentren und Datenquellen hinzugef眉gt, die rund 2,7 Millionen kardiovaskul盲re Untersuchungen pro Jahr beitragen. Diese Erweiterung macht OneMedNet zu einem der gr枚脽ten Anbieter kardiovaskul盲rer RWD.
Das erweiterte Netzwerk stellt anonymisierte kardiovaskul盲re Bilddaten, Diagnostikberichte und Elektrokardiogramme (EKG) f眉r Life-Sciences-Unternehmen, KI-Entwickler und Medizin Ger盲tehersteller bereit. Diese Daten sind besonders wertvoll, da kardiovaskul盲re Erkrankungen (CVD) weltweit 19,8 Millionen Todesf盲lle verursachen und allein in den USA 320 Milliarden Dollar an j盲hrlichen Kosten erzeugen.
- Addition of 85 cardiovascular centers expanding data network coverage
- Positioning as one of the largest providers of Cardiovascular AG真人官方-World Data
- Access to large addressable market with CVD generating $320B annually in US costs
- Continuous data updates ensuring current and relevant information for clients
- None.
Insights
OneMedNet significantly expanded its cardiovascular data network, positioning it as a premier provider of real-world clinical data for healthcare innovation.
OneMedNet has made a strategic expansion of its cardiovascular data network, adding 85 cardiovascular centers that will contribute 2.7 million annual cardiovascular studies to its platform. This positions the company as one of the largest providers of cardiovascular real-world data (RWD) in the industry.
The timing of this expansion is particularly significant given the massive scale of cardiovascular disease burden: CVDs cause
This expanded network delivers substantial value through de-identified cardiovascular imaging, diagnostic reports, and electrocardiograms (ECGs) at unprecedented scale. The data is continuously updated, making it especially valuable for pharmaceutical companies accelerating R&D efforts, AI developers training specialized algorithms, insurance companies managing risk profiles, and medical device manufacturers seeking regulatory approval.
The real competitive advantage here is the combination of scale, clinical depth, and continuous updating of the data. Most competing data providers offer either breadth or depth, but rarely both with real-time updates. This expansion transforms OneMedNet's offering into a comprehensive ecosystem rather than just a data repository.
For life sciences companies specifically, this expansion provides access to longitudinal patient data that can dramatically reduce time-to-market for new therapies by enabling more targeted research and faster evidence generation for regulatory submissions. The continuously refreshed nature of the data means companies can identify emerging treatment patterns and outcomes much faster than with traditional clinical data sources.
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (鈥淥neMedNet鈥� or the 鈥淐ompany鈥�), a leader in AI-powered AG真人官方-World Data (RWD), announced the addition of 85 cardiovascular centers and data sources, expanding its Cardiovascular network thereby positioning OneMedNet as one of the largest providers for Cardiovascular AG真人官方-World data.
Cardiovascular diseases (CVDs) remain the world鈥檚 leading cause of death, responsible for approximately 19.8 million deaths in 2022, accounting for roughly
Such pervasive health and financial pressures make OneMedNet鈥檚 enriched multimodal cardiovascular data network ideally suited for pharmaceutical and insurance sectors. For drug developers, this real-time, expansive data offers deeper insights into disease progression, treatment responses, and outcomes鈥攆ueling more efficient, evidence-based R&D and accelerating the development of novel therapeutics.
This expansion enhances OneMedNet鈥檚 network, delivering de-identified cardiovascular imaging, diagnostic reports, and electrocardiograms (ECG) at unprecedented scale and clinical depth to life sciences companies, AI developers, and medical device manufacturers, with data that is continually updated to reflect the latest clinical insights and advancements.
The addition of these new sites solidifies OneMedNet鈥檚 position as the premier source for high-quality, regulatory-grade cardiovascular RWD, fueling innovation, supporting clinical evidence generation, and improving patient outcomes through the most robust ecosystem in the industry.
鈥淏y combining de-identified cardiovascular imaging, structured reports, and ECG signals from this vast network, we鈥檙e providing real-world clinical insights that accelerate innovation in diagnostics, therapeutics, and AI model development. This is the clinically rich, longitudinal data the industry has been demanding鈥攁nd we鈥檙e delivering it at scale, with continual updates ensuring the most current and relevant information,鈥� said Aaron Green, President and CEO of OneMedNet.
- World Health Organization Cardiovascular Disease 鈥�
- World Heart Federation 2025 Report -
About OneMedNet Corporation
OneMedNet is revolutionizing how the world unlocks AG真人官方-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD鈩� platform. This isn鈥檛 just data鈥攊t鈥檚 the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.
Beyond healthcare OneMedNet鈥檚 proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities鈥攔igorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at .
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as 鈥渕ay,鈥� 鈥渟hould,鈥� 鈥渆xpects,鈥� 鈥渁nticipates,鈥� 鈥渃ontemplates,鈥� 鈥渆stimates,鈥� 鈥渂elieves,鈥� 鈥減lans,鈥� 鈥減rojected,鈥� 鈥減redicts,鈥� 鈥減otential,鈥� or 鈥渉opes鈥� or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin鈥檚 volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations.
OneMedNet Contacts:
Michael Wong, VP Marketing
Email: [email protected]
FAQ
What expansion did OneMedNet (ONMD) announce in August 2025?
How large is the cardiovascular disease market that OneMedNet (ONMD) is targeting?
What type of data does OneMedNet (ONMD) provide through its cardiovascular network?
Who are the main customers for OneMedNet's (ONMD) cardiovascular data?
